Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

Jo Lemoine said she refuses to let cancer take her down. “I’m just full of gratitude, and I can’t wait to get back to work." ...

Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's du ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

The end-to-end space transportation company looks to its future launch, lunar and on-orbit services and capabilities.

In an interview with Targeted Oncology, Michael Mauro, MD, delved into the rapidly advancing field of chronic myeloid ...

Started 25 years ago, the DACC has helped people experiencing homelessness clear criminal cases and instead, connect to ...